BackgroundCheck.run
Search For

Kenny Em Wong, 57Augusta, GA

Known as:
Ken Em Wong Ken E Wong Kin C Wong Kin H Wong Ken Won Ken Wang Kenny Ong
Related to:
Xinfei Wang

Kenny Wong Phones & Addresses

Augusta, GA   

Buffalo, NY   

Colonial Heights, VA   

Brooklyn, NY   

Sewell, NJ   

Work

Company: Morgan stanley Oct 2009 Position: Manager - hr investment banking division and global capital markets

Education

School / High School: Pace University- New York, NY Sep 2003 Specialities: Bachelor of Science in Finance
Get Report
Control this profile

Mentions for Kenny Em Wong

Kenny Wong resumes & CV records

Resumes

Kenny Wong Photo 50

Kenny Wong - Jersey City, NJ

Work:
Morgan Stanley Oct 2009 to 2000
Manager - HR Investment Banking Division and Global Capital Markets Goldman Sachs & Co - New York, NY Aug 2008 to Oct 2009
Human Capital Management - Pro Unlimited Corporate Services & Real Estate May 2006 to Aug 2008
Consultant Human Capital Management Jul 1999 to May 2006
Analyst, Consultant through ProUnlimited and Intern
Education:
Pace University - New York, NY Sep 2003 to Jan 2006
Bachelor of Science in Finance St. John's University - Jamaica, NY Sep 2001 to Jun 2003 Pace University
Finance Club

Publications & IP owners

Us Patents

Murd Protein And Gene Of Staphylococcus Aureus

US Patent:
6534284, Mar 18, 2003
Filed:
May 3, 2000
Appl. No.:
09/530836
Inventors:
Mohammed El-Sherbeini - Rahway NJ
Kenny Kin Wong - Rahway NJ
Wayne M. Geissler - Rahway NJ
Assignee:
Merck Co., Inc. - Rahway NJ
International Classification:
C07H 2104
US Classification:
435 691, 435 701, 435 711, 435183, 435193, 43525211, 4353201, 435325, 536 232, 536 237
Abstract:
This invention provides the murD gene of Purified and isolated MurD recombinant proteins are also provided. Nucleic acid sequences which encode functionally active MurD proteins are described. Assays for the identification of modulators of the expression of murD and inhibitors of the activity of MurD, are also provided.

Murd Protein And Gene Of Streptococcus Pyogenes

US Patent:
6746858, Jun 8, 2004
Filed:
May 3, 2000
Appl. No.:
09/530838
Inventors:
Mohammed El-Sherbeini - Rahway NJ
Kenny Kin Wong - Rahway NJ
Assignee:
Merck Co. Inc. - Rahway NJ
International Classification:
C12N 900
US Classification:
435183, 435 691, 4353201, 4352523, 43525411, 536 232
Abstract:
This invention provides the murD gene of Purified and isolated MurD recombinant proteins are also provided. Nucleic acid sequences which encode functionally active MurD proteins are described. Assays for the identification of modulators of the expression of murD and inhibitors of the activity of MurD, are also provided.

Substituted 2-Aminopyridines As Inhibitors Of Nitric Oxide Synthase

US Patent:
5972975, Oct 26, 1999
Filed:
May 22, 1997
Appl. No.:
8/836953
Inventors:
Craig Esser - Rahway NJ
William Hagmann - Rahway NJ
William Hoffman - Rahway NJ
Shrenik Shah - Rahway NJ
Kenny Wong - Rahway NJ
Renee Chabin - Rahway NJ
Ravindra Guthikonda - Rahway NJ
Malcolm Maccoss - Rahway NJ
Charles Caldwell - Rahway NJ
Philippe Durette - Rahway NJ
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 3144
C07D21375
US Classification:
514352
Abstract:
Substituted 2-aminopyridine compounds of Formula (I) and pharmaceutically acceptable salts which have been found useful in the treatment of nitric oxide synthase mediated diseases and disorders. ##STR1##.

Metabolic Pathway Assay

US Patent:
5891621, Apr 6, 1999
Filed:
Sep 24, 1997
Appl. No.:
8/936646
Inventors:
Renee M. Chabin - Neptune NJ
David W. Kuo - Princeton NJ
John F. O'Connell - Cranbury NJ
David L. Pompliano - Lawrenceville NJ
Kenny K. Wong - Edison NJ
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C12Q 100
C12Q 137
C12Q 118
C12Q 148
US Classification:
435 4
Abstract:
An in vitro screening assay which identifies enzyme inhibitors and allows for the simultaneous assay of many enzymes. Enzyme, substrate, co-factor, etc. concentrations are optimized so that inhibitors of any one of the enzymes in the pathway are equally likely to be detected. Necessarily, the flux of substrate through each enzyme should be nearly the same during the assay, i. e. , each of the enzyme catalyzed steps must be equally rate-limiting. Preferably, optimal assay conditions are predicted by computer modeling. Further, the pathway conditions are optimized through variation of enzyme, starting substrate, co-substrate and co-factor concentrations. A positive response is initially detected as a change in the amount of the product generated at the end of the enzyme cascade as compared to a standard. A sample producing a positive result can be deconvoluted.

Isbn (Books And Publications)

5Th Ieee International Workshop On Web Site Evolution: Theme, Architecture Proceedings Amsterdam, The Netherlands, 22 September 2003

Author:
Kenny Wong
ISBN #:
0769520162

Possible Relatives

Cynthia W Wong  David K Wong  Cyrus L Wong  Davin R Wong  Davina H Wong  Dawson J Wong  Dean Wong  Kenny Johnson  Kenny L Stanford  Kenny Jones 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.